Related Experiment Video
Updated: May 10, 2026

10:08
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
Published on: November 22, 2024
Encryption and decryption of tissue factor
1Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.
Journal of Thrombosis and Haemostasis : JTH
|July 2, 2013
Summary
Tissue factor (TF) regulates blood clotting and thrombus formation. Its decryption on myeloid cells involves a dithiol/disulfide switch, potentially mediated by protein disulfide isomerase, but the exact mechanism requires further investigation.
Area of Science:
- Biochemistry
- Hematology
- Cell Biology
Background:
- Tissue factor (TF) is a key initiator of blood coagulation, binding and activating factor VIIa (FVIIa).
- The TF/FVIIa complex generates thrombin, crucial for stable thrombus formation.
- TF exists in both extravascular and intravascular compartments, with distinct regulatory mechanisms.
Purpose of the Study:
- To investigate the mechanisms regulating intravascular TF activity, particularly its decryption on leucocytes.
- To explore the role of dithiol/disulfide bonds and phosphatidylserine exposure in TF decryption.
- To examine the involvement of purinergic receptors, complement activation, and protein disulfide isomerase in TF decryption.
Main Methods:
- Review of experimental observations on TF decryption.
- Analysis of the proposed dithiol/disulfide switch involving the Cys186-Cys209 bond in TF.
- Examination of studies implicating purinergic receptors, complement, and protein disulfide isomerase in TF regulation.
Main Results:
- Intravascular TF primarily originates from leucocytes (monocytes/neutrophils) and exists in a cryptic, non-coagulant form.
- Acute events trigger local TF decryption and subsequent FX activation.
- Decryption involves a dithiol/disulfide switch and phosphatidylserine exposure, with protein disulfide isomerase implicated.
Conclusions:
- TF decryption on myeloid cells is linked to purinergic receptor or complement activation.
- A dithiol/disulfide switch, potentially involving protein disulfide isomerase, is central to TF decryption.
- The precise molecular mechanism of protein disulfide isomerase in TF encryption/decryption remains to be elucidated.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

